See more : GDS Holdings Limited (GDS) Income Statement Analysis – Financial Results
Complete financial analysis of Imagion Biosystems Limited (IBXXF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Imagion Biosystems Limited, a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
- Endo International plc (ENDP) Income Statement Analysis – Financial Results
- Yunhong International (ZGYHR) Income Statement Analysis – Financial Results
- Gores Holdings VII, Inc. (GSEVW) Income Statement Analysis – Financial Results
- Etsy, Inc. (ETSY) Income Statement Analysis – Financial Results
- TUGA Innovations, Inc. (TUGAF) Income Statement Analysis – Financial Results
Imagion Biosystems Limited (IBXXF)
About Imagion Biosystems Limited
Imagion Biosystems Limited provides medical imaging technologies based on superparamagnetic relaxometry for cancer and disease detection, and monitoring therapy. It has activities in nanotechnology; biotechnology; cancer diagnostics; and superparamagnetic relaxometry. The company develops MagSense, which is in Phase I clinical trials for the treatment of HER2 breast cancers; and PrecisionMRX, an iron oxide nanoparticle to detect cancer. Imagion Biosystems Limited has a collaborative research program with Patrys Limited to use the combined technologies for enhancing brain tumor imaging and diagnosis; and a joint development agreement with Global Cancer Technology, Inc. to develop GCT's novel nanoscintillator technology for the treatment of breast cancer. The company was incorporated in 2016 and is based in San Diego, California.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.37M | 473.43K | 232.87K | 205.72K | 410.85K | 191.48K | 20.10K | 12.00 | 5.49K | 6.11K |
| Cost of Revenue | 5.25M | 3.62M | 2.70M | 2.86M | 2.27M | 3.30M | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | -3.88M | -3.14M | -2.47M | -2.66M | -1.86M | -3.10M | 20.10K | 12.00 | 5.49K | 6.11K |
| Gross Profit Ratio | -283.96% | -663.76% | -1,061.20% | -1,290.63% | -452.27% | -1,621.19% | 100.00% | 100.00% | 100.00% | 100.00% |
| Research & Development | 5.25M | 3.62M | 2.70M | 2.86M | 2.27M | 3.30M | 2.16M | 6.02M | 3.88M | 2.24M |
| General & Administrative | 6.70M | 5.52M | 3.76M | 2.82M | 1.82M | 3.97M | 2.72M | 514.32K | 245.79K | 86.77K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 6.70M | 5.52M | 3.76M | 2.82M | 1.82M | 3.97M | 2.72M | 514.32K | 245.79K | 86.77K |
| Other Expenses | 0.00 | 2.57M | 2.61M | 2.42M | 2.02M | 587.95K | 236.81K | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 1.37M | 12.70M | 8.87M | 7.96M | 5.88M | 9.15M | 7.20M | 12.41M | 4.13M | 2.33M |
| Cost & Expenses | 16.53M | 12.70M | 8.87M | 7.96M | 5.88M | 9.15M | 7.20M | 12.41M | 4.13M | 2.33M |
| Interest Income | 69.20K | 29.83K | 10.54K | 5.34K | 21.79K | 36.96K | 81.62K | 0.00 | 276.00K | 195.53K |
| Interest Expense | 985.70K | 1.99K | 4.30K | 6.47K | 9.16K | 7.75K | 935.27K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 1.18M | 1.11M | 404.44K | 360.57K | 141.99K | 213.79K | 206.83K | 259.70K | 155.17K | 47.66K |
| EBITDA | -10.30M | -8.70M | -5.62M | -5.00M | -3.28M | -8.12M | -6.65M | -6.54M | -3.97M | -2.27M |
| EBITDA Ratio | -753.58% | -1,837.03% | -2,411.68% | -2,429.05% | -798.67% | -4,239.92% | -33,093.74% | -54,492,900.00% | -72,274.99% | -37,179.98% |
| Operating Income | -11.75M | -9.81M | -6.02M | -5.36M | -3.42M | -8.33M | -6.86M | -6.80M | -4.12M | -2.32M |
| Operating Income Ratio | -859.02% | -2,071.11% | -2,585.36% | -2,604.33% | -833.23% | -4,351.57% | -34,122.66% | -56,657,100.00% | -75,099.99% | -37,959.99% |
| Total Other Income/Expenses | -726.97K | -175.74K | -9.78K | -105.14K | 2.04M | 617.15K | -935.27K | -5.61M | -276.00K | -195.53K |
| Income Before Tax | -12.47M | -9.81M | -6.02M | -5.36M | -3.43M | -8.34M | -7.79M | -12.41M | -4.40M | -2.51M |
| Income Before Tax Ratio | -912.18% | -2,071.53% | -2,587.21% | -2,607.47% | -835.46% | -4,355.62% | -38,775.26% | -103,447,700.00% | -80,124.99% | -41,159.99% |
| Income Tax Expense | 0.00 | 2.57M | 2.61M | 2.43M | 2.03M | 595.70K | 1.17M | 0.00 | 0.00 | 0.00 |
| Net Income | -12.47M | -9.81M | -6.02M | -5.36M | -3.43M | -8.34M | -7.79M | -12.41M | -4.40M | -2.51M |
| Net Income Ratio | -912.18% | -2,071.53% | -2,587.21% | -2,607.47% | -835.46% | -4,355.62% | -38,775.26% | -103,447,700.00% | -80,124.99% | -41,159.99% |
| EPS | -0.41 | -0.01 | -0.01 | -0.01 | -0.01 | -0.04 | -0.04 | -4.85 | -214.69 | -122.69 |
| EPS Diluted | -0.41 | -0.01 | -0.01 | -0.01 | -0.01 | -0.04 | -0.04 | -4.85 | -214.68 | -122.68 |
| Weighted Avg Shares Out | 30.48M | 1.12B | 1.05B | 747.08M | 362.96M | 234.27M | 183.55M | 2.56M | 20.50K | 20.50K |
| Weighted Avg Shares Out (Dil) | 30.48M | 1.12B | 1.05B | 747.08M | 362.96M | 234.27M | 183.55M | 2.56M | 20.50K | 20.50K |
Source: https://incomestatements.info
Category: Stock Reports